PAVmed (PAVM) EBITDA Margin (2021 - 2025)
PAVmed (PAVM) reported EBITDA Margin of -8376.54% for Q4 2025, up 42803.46 percentage points from -51180.00% a year earlier and up 88063.46 percentage points from the prior quarter.
Powered by 
Analysis
PAVmed (PAVM) EBITDA Margin (2021 - 2025) Analysis & Trends
For FY2025, PAVmed posted EBITDA Margin of -21701.00%, down 20255.62 percentage points from FY2024.
- EBITDA Margin has a four-year change of -10896.80 percentage points (FY2021 to FY2025).
- By year, EBITDA Margin came in at -1445.38% in FY2024 (+1240.72 pp), -2686.09% in FY2023 (+20823.19 pp), -23509.28% in FY2022 (-12705.08 pp) and -10804.20% in FY2021.
- The Q4 2025 figure ranks as the highest quarterly EBITDA Margin since Q2 2024.
- Year over year, EBITDA Margin gained in three of the last six quarters, with an average year-over-year change of -23124.45 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q4 2025 (a gain of 42803.46 percentage points); the low point was Q2 2025 (a drop of 76850.07 percentage points).
- Per Business Quant data, the three quarters before Q4 2025 came in at -96440.00% (Q3 2025), -78216.67% (Q2 2025) and -67537.50% (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 31.93% |
| 10 | PAVmed | 90.10 Mn | 61.93 Mn | -89,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -8,376.54% |
| Sep 30, 2025 | -96,440.00% |
| Jun 30, 2025 | -78,216.67% |
| Mar 31, 2025 | -67,537.50% |
| Dec 31, 2024 | -51,180.00% |
| Jun 30, 2024 | -1,366.60% |
| Mar 31, 2024 | -1,331.68% |
| Dec 31, 2023 | -1,492.66% |
| Sep 30, 2023 | -1,870.42% |
| Jun 30, 2023 | -9,480.12% |
| Mar 31, 2023 | -4,411.21% |
| Dec 31, 2022 | -21,316.96% |
| Sep 30, 2022 | -29,825.00% |
| Mar 31, 2022 | -10,209.52% |
| Dec 31, 2021 | -6,504.33% |
| Sep 30, 2021 | -6,818.00% |
API Access
PAVmed EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PAVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PAVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PAVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();